Targeting DNA2 Overcomes Metabolic Reprogramming in 1q21 Multiple Myeloma

Authors

• Natthakan Thongon, The University of Texas MD Anderson Cancer Center
• Feiyang Ma, The University of Texas MD Anderson Cancer CenterFollow
• Matteo Marchesini, The University of Texas MD Anderson Cancer Center
• Jintan Liu, The University of Texas MD Anderson Cancer Center
• Natalia Baran, The University of Texas MD Anderson Cancer Center
• Pamela Lockyer, The University of Texas MD Anderson Cancer Center
• Andrea Santoni, The University of Texas MD Anderson Cancer Center
• Christopher Jackson, The University of Texas MD Anderson Cancer Center
• Ashley Rose, The University of Texas MD Anderson Cancer Center
• Irene Ganan-Gomez, The University of Texas MD Anderson Cancer Center
• Vera Adema, The University of Texas MD Anderson Cancer Center
• Valentina Marchica, University of Parma
• Paola Storti, University of Parma
• Nicola Giuliani, University of Parma
• Guillermo Montalban-Bravo, The University of Texas MD Anderson Cancer Center
• Yun Qing, The University of Texas MD Anderson Cancer Center
• Min Ha, The University of Texas MD Anderson Cancer Center
• Rodrigo Fonseca, Mayo Clinic
• Caleb Class, Bulter University
• Lin Tan, The University of Texas MD Anderson Cancer Center
• Rashmi Kanagal-Shamanna, The University of Texas MD Anderson Cancer Center
• David Berrios Nolasco, The University of Texas MD Anderson Cancer Center
• Marina Konopleva MD, PhD, The University of Texas MD Anderson Cancer CenterFollow
• Philip L. Lorenzi, The University of Texas MD Anderson Cancer Center
• Guillermo Garcia-Manero MD, The University of Texas MD Anderson Cancer Center
• Elisabet Manasanch, The University of Texas MD Anderson Cancer Center
• Marta Chesi, The University of Texas MD Anderson Cancer Center
• Simona Colla, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00090

Publication Date

2022

Keywords

Novel Therapeutic Targets for Cancers

Department

Leukemia

Research Category

Other

Recommended Citation

Thongon, Natthakan; Ma, Feiyang; Marchesini, Matteo; Liu, Jintan; Baran, Natalia; Lockyer, Pamela; Santoni, Andrea; Jackson, Christopher; Rose, Ashley; Ganan-Gomez, Irene; Adema, Vera; Marchica, Valentina; Storti, Paola; Giuliani, Nicola; Montalban-Bravo, Guillermo; Qing, Yun; Ha, Min; Fonseca, Rodrigo; Class, Caleb; Tan, Lin; Kanagal-Shamanna, Rashmi; Berrios Nolasco, David; Konopleva, Marina MD, PhD; Lorenzi, Philip L.; Garcia-Manero, Guillermo MD; Manasanch, Elisabet; Chesi, Marta; and Colla, Simona, "Targeting DNA2 Overcomes Metabolic Reprogramming in 1q21 Multiple Myeloma" (2022). Leading Edge of Cancer Research Symposium 2022. 19.
doi:https://doi.org/10.52519/00090